Agilon Health (AGL) Competitors $2.23 -0.08 (-3.46%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$2.24 +0.01 (+0.27%) As of 07/11/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AGL vs. SHC, SGRY, CON, PRVA, WGS, VCYT, ADUS, ARDT, PACS, and LFSTShould you be buying Agilon Health stock or one of its competitors? The main competitors of Agilon Health include Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), Addus HomeCare (ADUS), Ardent Health (ARDT), PACS Group (PACS), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. Agilon Health vs. Its Competitors Sotera Health Surgery Partners Concentra Group Holdings Parent Privia Health Group GeneDx Veracyte Addus HomeCare Ardent Health PACS Group LifeStance Health Group Agilon Health (NYSE:AGL) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership. Do analysts rate AGL or SHC? Agilon Health currently has a consensus price target of $4.71, suggesting a potential upside of 111.40%. Sotera Health has a consensus price target of $16.00, suggesting a potential upside of 35.59%. Given Agilon Health's higher probable upside, equities research analysts plainly believe Agilon Health is more favorable than Sotera Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilon Health 2 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.17Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Do insiders and institutionals have more ownership in AGL or SHC? 91.0% of Sotera Health shares are held by institutional investors. 3.6% of Agilon Health shares are held by insiders. Comparatively, 47.6% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor AGL or SHC? In the previous week, Agilon Health had 3 more articles in the media than Sotera Health. MarketBeat recorded 5 mentions for Agilon Health and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.18 beat Agilon Health's score of -0.22 indicating that Sotera Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilon Health 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is AGL or SHC more profitable? Sotera Health has a net margin of 2.24% compared to Agilon Health's net margin of -4.04%. Sotera Health's return on equity of 41.08% beat Agilon Health's return on equity.Company Net Margins Return on Equity Return on Assets Agilon Health-4.04% -45.47% -12.76% Sotera Health 2.24%41.08%5.68% Which has more risk and volatility, AGL or SHC? Agilon Health has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500. Which has better valuation & earnings, AGL or SHC? Sotera Health has lower revenue, but higher earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilon Health$6.06B0.15-$260.15M-$0.59-3.78Sotera Health$1.10B3.04$44.34M$0.08147.50 SummarySotera Health beats Agilon Health on 12 of the 16 factors compared between the two stocks. Get Agilon Health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricAgilon HealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$923.11M$7.32B$5.56B$20.62BDividend YieldN/A2.84%5.06%3.72%P/E Ratio-3.7834.5428.2627.81Price / Sales0.1535.93408.4840.78Price / CashN/A23.1337.1222.32Price / Book1.966.858.044.57Net Income-$260.15M$236.02M$3.19B$989.30M7 Day Performance-6.93%0.01%3.62%0.20%1 Month Performance3.48%2.76%5.98%5.53%1 Year Performance-64.55%33.80%29.39%10.30% Agilon Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLAgilon Health2.3285 of 5 stars$2.23-3.5%$4.71+111.4%-64.5%$923.11M$6.06B-3.781,076News CoverageAnalyst ForecastSHCSotera Health3.1545 of 5 stars$11.40-2.9%$16.00+40.4%-4.5%$3.24B$1.11B142.523,000SGRYSurgery Partners2.473 of 5 stars$22.03-0.5%$33.56+52.3%-18.0%$2.82B$3.11B-14.4015,000CONConcentra Group Holdings Parent2.9128 of 5 stars$20.33-1.1%$28.50+40.2%N/A$2.61B$1.90B15.1711,250News CoveragePRVAPrivia Health Group4.5032 of 5 stars$21.35-3.4%$27.77+30.1%+14.2%$2.60B$1.80B177.931,140News CoverageAnalyst ForecastWGSGeneDx3.8448 of 5 stars$85.74-6.4%$90.13+5.1%+151.7%$2.45B$305.45M-60.811,200Trending NewsAnalyst ForecastInsider TradeVCYTVeracyte3.588 of 5 stars$26.34-4.3%$40.90+55.3%+19.0%$2.06B$445.76M64.25790ADUSAddus HomeCare4.9782 of 5 stars$110.62-1.1%$142.57+28.9%-8.3%$2.04B$1.15B24.9749,703Positive NewsARDTArdent Health3.3471 of 5 stars$13.34-0.4%$20.67+54.9%N/A$1.91B$5.97B8.1824,900News CoverageAnalyst DowngradePACSPACS Group2.814 of 5 stars$12.51-4.8%$34.29+174.1%-59.2%$1.91B$3.11B0.0032,433LFSTLifeStance Health Group3.0932 of 5 stars$4.68-2.3%$8.50+81.6%-15.4%$1.86B$1.28B-46.8010,218News Coverage Related Companies and Tools Related Companies Sotera Health Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives GeneDx Alternatives Veracyte Alternatives Addus HomeCare Alternatives Ardent Health Alternatives PACS Group Alternatives LifeStance Health Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AGL) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilon Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilon Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.